Nasdaq

ALK Announces U.S. FDA Approval of New AccuTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis

– The innovative AccuTest™ features a range of single prick and multi-head skin testing devices and well trays to improve the accuracy of allergy diagnosis and testing – The AccuTest™ allergen well ...
Nasdaq

ALK to Become Sole Manufacturer and Distributor of Skin Antigen Test for Penicillin Allergy

– PRE-PEN® (benzylpenicilloyl polylysine injection USP) is the only FDA-approved diagnostic skin test for the evaluation of penicillin allergyi,ii – BEDMINSTER, N.J., Jan. 4, 2024 /PRNewswire/ -- The ...
Benzinga.com

Response Genetics, Inc. to Offer Enhanced ALK Testing Program for Metastatic Lung Cancer Patients

Response Genetics, Inc. RGDX, a company focused on the development and sale of molecular diagnostic tests for cancer, today announced a new anaplastic lymphoma kinase (ALK) testing program aimed to ...
technologynetworks

Response Genetics, Inc. to Offer FDA-Approved Anaplastic Lymphoma Kinase (ALK) Test for Metastatic NSCLC

Approximately 3 to 5 percent of NSCLC tumors have a rearrangement of the ALK gene, which can lead to impaired programmed cell death and abnormal cell growth. Using the new ALK Break Apart FISH Probe ...
The American Journal of Managed Care

Alectinib Significantly Improves Disease-Free Survival in ALK-Positive NSCLC

Seeking more data on adjuvant alectinib in patients who have resectable ALK-positive non–small cell lung cancer (NSCLC), investigators compared outcomes vs chemotherapy. ALK-positive disease accounts ...
Seeking Alpha

ALK Announces U.S. FDA Approval of New AccuTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis

– The innovative AccuTest™ features a range of single prick and multi-head skin testing devices and well trays to improve the accuracy of allergy diagnosis and testing – BEDMINSTER, N.J., Oct. 7, 2024 ...